spacer
home > pmps > winter 2003 > take the hassle out of buying a vessel
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Take the Hassle Out of Buying a Vessel

Purchasing new process vessels for the pharmaceutical industry is often a time-consuming and onerous task. The industry is required to ensure that their new equipment meets with current legislation, operating procedures and approvals, as well as ensuring that any ancillary equipment is fully integrated for successful operation.

For process engineers wishing to purchase a new vessel there are a number of procedures to go through before a vessel and any ancillary equipment is fully operational. These procedures can be very time consuming, and if not administered correctly can create unnecessary delays and hassle. This article breaks these procedures down into categories and also indicates the best methods that engineers should adopt when purchasing new vessels.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Paul Mayer, Sales Director at Braby

A qualified Mechanical Engineer, Paul Mayer's first position was as a Production Engineer in a large UK print engineering company. He soon progressed to managing the production area responsible for the co-ordination of the entire plant manufacturing process. After several years, and following a period of skills training, Paul assumed the role of Commercial Manager for the same organisation working with a large international customer base. This lead to his appointment as Head of the sales force, which covered most of the world market. Paul joined Braby in 1997 and managed the sales force becoming Director of Sales and Marketing. He and his team have lead Braby into many new market areas and developed the single source approach for prospective customers.

spacer
Paul Mayer
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) a subsidiary of WuXi AppTec and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement